SCHEMBL14435392

SCHEMBL14435392

Bc1cnccc1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Amifampridine SCHEMBL21273 0.80
Amifampridine SCHEMBL29354458 0.80
Amifampridine SCHEMBL30609183 0.78
Amifampridine SCHEMBL8907371 0.78 GAA (0.56)
Amifampridine SCHEMBL28271256 0.78
Amifampridine SCHEMBL19410631 0.78 GAA (0.56)
Amifampridine SCHEMBL11016903 0.78
Amifampridine SCHEMBL8907368 0.78 GAA (0.56)
Amifampridine SCHEMBL28271266 0.76 GAA (0.54)
Amifampridine SCHEMBL27516080 0.74 GAA (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007092000-A1 INHIBITORS OF HCV REPLICATION BRISTOL-MYERS SQUIBB COMPANY (US) 2007-08-16 WO disclosed